Find clinical trials for Prostate Cancer in Atlanta, GA
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Prostate Cancer trials near Atlanta, GA, USA:
therapy in participants with metastatic castration-resistant prostate cancer (mCRPC) comprising 2 phases: a Phase 1 Dose Escalation...
Phase 1, Phase 2
Atlanta, Georgia, United States and 9 other locations
of this study is to evaluate the safety, tolerability, and antitumour activity of AZD0754 CAR T-cell therapy in participants with metastatic prostate...
Phase 1, Phase 2
Atlanta, Georgia, United States and 7 other locations
This is a phase 1 study to assess the safety and tolerability of ARX517 in adult subjects with Metastatic Castration-Resistant Prostate Cancer...
Phase 1
Atlanta, Georgia, United States and 8 other locations
Evaluate the safety and tolerability of AMG 509 in adult participants and determine the maximum tolerated dose (MTD) or recommended phase 2 dose (RP2...
Phase 1
Atlanta, Georgia, United States and 44 other locations
To evaluate the safety and tolerability of Tarlatamab and will determine the maximum tolerated dose (MTD) or recommended phase 2 dose (RP2D).
Phase 1
Atlanta, Georgia, United States and 20 other locations
ADT using Degarelix (LHRH antagonist) for men with hormone-sensitive prostate cancer and a rising prostate-specific antige...
Phase 1, Phase 2
Atlanta, Georgia, United States and 3 other locations
injection for biomarker targeted MR molecular imaging (MRMI) of prostate cancer in patients scheduled for radical prostatectomy....
Phase 1, Phase 2
Atlanta, Georgia, United States
clinical efficacy in participants with metastatic hormone-sensitive prostate cancer (mHSPC) by progression-free survival.The resear...
Phase 2
Atlanta, Georgia, United States and 28 other locations
plus prednisone in participants with metastatic castration resistant prostate cancer. Prednisolone may be used instead of prednison...
Phase 2, Phase 3
Atlanta, Georgia, United States and 105 other locations
Eligible patients will be treated with the combination of lenvatinib and pembrolizumab. A cycle equals 21 days and therapy will continue until radiog...
Phase 2
Atlanta, Georgia, United States and 4 other locations
Clinical trials
Research sites
Resources
Legal